Skip to main content

Table 4 Adjusted marginal (overall) and conditional (severity category) effects of MTC on ACR20 response for the full population, with the missing ACR20 responses imputed through a causal prediction method

From: Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis

 

Visits analyzed (12,094 visits; 1776 patients)*

Visits with MTC, % ACR20 response (95% CI)

Visits without MTC, % ACR20 response (95% CI)

RD (95% CI)

RR (95% CI)

DAS28 category

 Overall effect

12.7 (11.2–14.1)

7.3 (6.8–7.0)

5.4 (4.0–6.0)

1.7 (1.5–2.0)

 Remission and low (< 3.20)

2.0 (0.9–3.4)

1.2 (0.8–1.7)

0.9 (− 0.4–2.3)

1.7 (0.7–3.4)

 Low moderate (3.20–4.02)

10.8 (7.8–14.2)

5.1 (4.0–6.7)

5.7 (2.4–9.3)

2.1 (1.4–3.1)

 High moderate (4.03–5.10)

19.7 (16.7–23.2)

12.2 (10.2–14.4)

7.4 (3.8–11.4)

1.6 (1.3–2.0)

 High (> 5.10)

34.7 (31.1–38.5)

20.2 (16.9–23.5)

14.5 (10.6–18.7)

1.7 (1.5–2.1)

CDAI category

 Overall effect

12.4 (11.0–13.8)

7.4 (6.9–7.2)

4.9 (3.4–5.5)

1.7 (1.5–1.9)

 Remission and low (< 10.0)

1.3 (0.5–2.5)

1.1 (0.7–1.6)

0.2 (− 0.8–1.3)

1.2 (0.4–2.6)

 Low moderate (10.0–12.9)

8.2 (4.5–13.0)

5.4 (3.9–7.3)

2.9 (− 1.2–7.7)

1.5 (0.8–2.7)

 High moderate (13.0–22.0)

20.3 (17.3–23.8)

10.3 (8.2–12.2)

10.0 (6.3–14.0)

2.0 (1.5–2.5)

 High (> 22.0)

31.2 (27.6–34.6)

19.8 (16.9–23.2)

11.4 (7.6–14.9)

1.6 (1.4–1.8)

RAPID3 category

 Overall effect

16.3 (14.5–17.2)

7.0 (6.1–7.6)

9.3 (7.4–10.7)

2.3 (2.0–2.7)

 Remission and low (< 2.00)

5.9 (3.5–8.8)

2.9 (2.0–3.9)

3.1 (0.6–5.9)

2.1 (1.2–3.4)

 Low moderate (2.00–3.81)

15.2 (12.2–18.4)

5.9 (4.8–7.3)

9.3 (6.1–12.7)

2.6 (1.9–3.4)

 High moderate (3.82–4.00)

11.8 (5.2–19.4)

6.5 (3.2–10.1)

5.3 (− 2.7–14.0)

1.8 (0.7–4.3)

 High (> 4.00)

22.3 (19.7–24.3)

9.7 (8.4–11.1)

12.5 (9.7–14.9)

2.3 (1.9–2.7)

  1. 95% CI 95% confidence interval, ACR20 20% improvement in American College of Rheumatology criteria, CDAI Clinical Disease Activity Index, DAS28 Disease Activity Score for 28 joints, MTC major therapeutic change, RAPID3 Routine Assessment of Patient Index Data 3, RD risk difference, RR risk ratio
  2. *Visits with data missing to calculate ACR20 responses imputed using a causal prediction method